Biowaivers and Biosimilars Reinforcing Intent and Content of Researchers and Regulators

Journal of Bioequivalence & Bioavailability
doi 10.4172/jbb.100000e17
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Roundtable on Biosimilars With European Regulators and Medical Societies, Brussels, Belgium, 12 January 2016

GaBI Journal
Drug GuidesPharmacy
2016English

Researchers, Regulators, and Sponsors Views on Pediatric Clinical Trials: A Multinational Study

Pediatrics
Child HealthPediatricsPerinatology
2016English

Biosimilars: Approval and Acceptance?

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2011English

Biowaivers-An Updated Review

Journal of Pharmaceutical Research
2017English

The First International Conference on SYNGAP1-related Brain Disorders: A Stakeholder Meeting of Families, Researchers, Clinicians, and Regulators

Journal of Neurodevelopmental Disorders
PediatricsCognitive NeurosciencePerinatologyNeurologyForensic MedicineChild HealthPathology
2018English

On the Reinforcing Effects of the Content of Verbal Attention.

Journal of Applied Behavior Analysis
Applied PsychologyPhilosophySociologyPolitical Science
1996English

New Insulins, Biosimilars, and Insulin Therapy

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2020English

Licensing and Prescribing Biosimilars in Australia

GaBI Journal
Drug GuidesPharmacy
2013English

Mistakes, Changed Circumstances and Intent

SSRN Electronic Journal
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy